Persistence of Hepatitis C Virus during and after Otherwise Clinically Successful Treatment of Chronic Hepatitis C with Standard Pegylated Interferon α-2b and Ribavirin Therapy

by Chen, Annie Y., Zeremski, Marija, Chauhan, Ranjit, Jacobson, Ira M., Talal, Andrew H., Michalak, Tomasz I.
Published 2013

Emerging therapies for the treatment of hepatitis C

by Lange, Christian M, Jacobson, Ira M, Rice, Charles M, Zeuzem, Stefan
Published 2014

Hepatitis C Virus: A Critical Appraisal of New Approaches to Therapy

by Nelson, David R., Jensen, Donald M., Sulkowski, Mark S., Everson, Greg, Fried, Michael W., Gordon, Stuart C., Jacobson, Ira, Reau, Nancy S., Sherman, Kenneth, Terrault, Nora, Thomas, David
Published 2012

HCV Council – critical appraisal of data: recommendations for clinical practice in a rapidly evolving therapeutic landscape

by Reau, Nancy, Fried, Michael W., Nelson, David R., Brown, Robert S., Everson, Gregory T., Gordon, Stuart C., Jacobson, Ira M., Lim, Joseph K., Pockros, Paul J., Reddy, K. Rajender, Sherman, Kenneth E.
Published 2015

Hepatitis C Viral Evolution in Genotype 1 Treatment-Naïve and Treatment-Experienced Patients Receiving Telaprevir-Based Therapy in Clinical Trials

by Kieffer, Tara L., De Meyer, Sandra, Bartels, Doug J., Sullivan, James C., Zhang, Eileen Z., Tigges, Ann, Dierynck, Inge, Spanks, Joan, Dorrian, Jennifer, Jiang, Min, Adiwijaya, Bambang, Ghys, Anne, Beumont, Maria, Kauffman, Robert S., Adda, Nathalie, Jacobson, Ira M., Sherman, Kenneth E., Zeuzem, Stefan, Kwong, Ann D., Picchio, Gaston
Published 2012